We had previously reported that FLT3 mutations have a negative impact on clinical outcomes in Mexican pediatric AML patients, and OS is significantly lower in patients with FLT3 mutations than in FLT3NEG (17, 37). Here, FLT3 is linked to acute myeloid leukemia.